Product NDC: | 55154-5731 |
Proprietary Name: | Acetylcysteine |
Non Proprietary Name: | Acetylcysteine |
Active Ingredient(s): | 200 mg/mL & nbsp; Acetylcysteine |
Administration Route(s): | ORAL; RESPIRATORY (INHALATION) |
Dosage Form(s): | INHALANT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-5731 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20110506 |
Package NDC: | 55154-5731-5 |
Package Description: | 5 VIAL in 1 BAG (55154-5731-5) > 4 mL in 1 VIAL |
NDC Code | 55154-5731-5 |
Proprietary Name | Acetylcysteine |
Package Description | 5 VIAL in 1 BAG (55154-5731-5) > 4 mL in 1 VIAL |
Product NDC | 55154-5731 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Acetylcysteine |
Dosage Form Name | INHALANT |
Route Name | ORAL; RESPIRATORY (INHALATION) |
Start Marketing Date | 20110506 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Cardinal Health |
Substance Name | ACETYLCYSTEINE |
Strength Number | 200 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Antidote [EPC],Antidote for Acetaminophen Overdose [EPC],Decreased Respiratory Secretion Viscosity [PE],Increased Glutathione Concentration [PE],Mucolytic [EPC],Reduction Activity [MoA] |